Podimetrics, founded with the mission to prevent diabetic foot ulcers (DFU), is a care management company leveraging advanced technology to improve patient outcomes and reduce healthcare costs. Their flagship product, the FDA-cleared SmartMat, allows high-risk diabetic patients to monitor their foot health by simply standing on the mat for 20 seconds daily. The data collected is automatically sent to Podimetrics' care management team, who triage any concerning findings, providing timely interventions. The company focuses on serving payers and at-risk providers to enhance patient care and prevent complications.
Notable figures affiliated with Podimetrics include healthcare professionals and technologists dedicated to innovative diabetes care. The company has garnered significant investment from leading venture capital firms and healthcare investors. Key achievements include FDA clearance for their SmartMat and successful partnerships with major healthcare providers. Podimetrics' impact is evident in its ability to save limbs, lives, and reduce medical expenses, particularly in underserved communities.